Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-γ

Shock

Volumn 27, Issue 3, 2007, Pages 289-295

  Murphey, E D ^a,b   Fang, Geping ^a   Varma, Tushar K ^a,b   Sherwood, Edward R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Cytokine; Endotoxin; Inflammation; Innate immunity; Pseudomonas

Indexed keywords

ENDOTOXIN; ESCHERICHIA COLI ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; PSEUDOMONAS AERUGINOSA ENDOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TOLERANCE; ESCHERICHIA COLI; INNATE IMMUNITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE; WILD TYPE;

ANIMALS; CYTOKINES; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 33847036222     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000245024.93740.28     Document Type: Article

References (32)

1. Medvedev AE, Sabroe I, Hasday JD, Vogel SN: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 12:133-150, 2006.
2. Varma TK, Toliver-Kinsky TE, Lin CY, Koutrouvelis AP, Nichols JE, Sherwood ER: Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun 69:5249-5263, 2001.
3. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M: Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9:101-107, 2003.
4. Yadavalli GK, Auletta JJ, Gould MP, Salata RA, Lee JH, Heinzel FP: Deactivation of the innate cellular immune response following endotoxic and surgical injury. Exp Mol Pathol 71:209-221, 2001.
5. Medvedev AE, Vogel SN: Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J Endotoxin Res 9:60-64, 2003.
6. Medvedev AE, Henneke P, Schromm A, Lien E, Ingalls R, Fenton MJ, Golenbock DT, Vogel SN: Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J Immunol 167:2257-2267, 2001.
7. Peck OM, Fan H, Tempel GE, Teti G, Halushka PV, Cook JA: Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. Shock 21:254-260, 2004.
8. Peck OM, Williams DL, Breuel KF, Kalbfleisch JH, Fan H, Tempel GE, Teti G, Cook JA: Differential regulation of cytokine and chemokine production in lipopolysaccharide-induced tolerance and priming. Cytokine 26:202-208, 2004.
9. Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G: Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28:3128-3136, 1998.
10. Randow F, Docke WD, Bundschuh DS, Hartung T, Wendel A, Volk HD: In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol 158:2911-2918, 1997.
11. Astiz ME, Saha DC, Brooks K, Carpati CM, Rackow EC: Comparison of the induction of endotoxin tolerance in endotoxemia and peritonitis by monophosphoryl lipid A and lipopolysaccharide. Circ Shock 39:194-198, 1993.
12. Echtenacher B, Mannel DN: Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J Endotoxin Res 8:365-369, 2002.
13. Lehner MD, Ittner J, Bundschuh DS, van Rooijen N, Wendel A, Hartung T: Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun 69:463-471, 2001.
14. Park DR: The microbiology of ventilator-associated pneumonia. Respir Care 50:742-763, 2005.
15. Tredget EE, Shankowsky HA, Rennie R, Burrell RE, Logsetty S: Pseudomonas infections in the thermally injured patient. Burns 30:3-26, 2004.
16. Varma TK, Durham M, Murphey ED, Cui W, Huang Z, Lin CY, Toliver-Kinsky T, Sherwood ER: Endotoxin priming improves clearance of Pseudomonas aeruginosa in wild-type and interleukin-10 knockout mice. Infect Immun 73:7340-7347, 2005.
17. Murphey ED, Herndon DN, Sherwood ER: Gamma interferon does not enhance clearance of Pseudomonas aeruginosa but does amplify a proinflammatory response in a murine model of postseptic immunosuppression. Infection and Immunity 72:6892-6901, 2004.
18. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN, Sherwood ER: Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 21:415-425, 2004.
19. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Annals of Surgery 222:482-490, 1995.
20. Toliver-Kinsky TE, Varma TK, Lin CY, Herndon DN, Sherwood ER: Interferon-gamma production is suppressed in thermally injured mice: decreased production of regulatory cytokines and corresponding receptors. Shock 18(4):322-330, 2002.
21. Ruggiero G, Andreana A, Utili R, Galante D: Enhanced phagocytosis and bactericidal activity of hepatic reticuloendothelial system during endotoxin tolerance. Infect Immun 27:798-803, 1980.
22. Echtenacher B, Falk W, Mannel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. Journal of Immunology 145:3762-3766, 1990.
23. Murphey ED, Traber DL: Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs. Crit Care Med 28:2015-2021, 2000.
24. Murphey ED, Traber DL: Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated, in part, by interleukin-10. Crit Care Med 29:1761-1766, 2001.
25. Sterns T, Pollak N, Echtenacher B, Mannel DN: Divergence of protection induced by bacterial products and sepsis-induced immune suppression. Infect Immun 73:4905-4912, 2005.
26. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA: Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31:1722-1729, 2003.
27. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O: Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness. Blood 89:1612-1620, 1997.
28. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W: Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678-681, 1997.
29. Licht AK, Schinkel C, Zedler S, Schinkel S, Faist E: Effects of perioperative recombinant human IFN-gamma (rHuIFN-gamma) application in vivo on T cell response. J Interferon Cytokine Res 23:149-154, 2003.
30. Held TK, Weihua X, Yuan L, Kalvakolanu DV, Cross AS: Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect Immun 67:206-212, 1999.
31. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN: Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 69:7271-7276, 2001.
32. Miles RH, Paxton TP, Dries DJ, Gamelli RL: Interferon-gamma increases mortality following cecal ligation and puncture. J Trauma Inj Infect Crit Care 36:607-611, 1994.